Tritonix.ai

News / Taiwan / cnyes

Lumosa Therapeutics August Revenue Skyrockets Over 5000% YoY

Health Technology · Biotechnology · cnyes · 2026-09-08

6535

Lumosa Therapeutics (6535) reported a massive 5,135.84% year-over-year revenue surge in August, with the stock outperforming the biotech sector index.

What Happened

Revenue Surge: Lumosa Therapeutics (6535) reported August 2026 revenue of NT$9.06 million, representing an extraordinary 5,135.84% year-over-year increase. The month-over-month growth was even more dramatic at 11,512.82%, indicating a significant shift in monthly revenue.

Year-to-Date Results: For the first eight months of 2026, cumulative revenue totaled NT$18.75 million, a modest 1.27% increase year-to-date. Despite the massive monthly spike, the cumulative growth remains relatively stable.

Stock and Market Data: The stock is trading at NT$77.8, up 4.01% over the past five days, outperforming the biotech industry index's 1.03% gain. Institutional investors have been net sellers, with foreign investors selling 225 shares.

Industry Context: Lumosa Therapeutics operates in the biotechnology sector. Investors should be aware of the high volatility associated with biotech stocks; these figures are for informational purposes only.

Read original

More in Health Technology

Xufu August Revenue Soars 187.52% Year-over-Year

Health Technology · cnyes · 2026-09-08

Xufu (4119) reported August 2026 revenue of NT$149 million, a 187.52% year-over-year surge, with year-to-date revenue growth at 14.21%.

4119

AstraZeneca Reports Positive Late-Stage Data for Tozorakimab in COPD Treatment

Health Technology · cnbc · 2026-09-08

AstraZeneca's experimental COPD drug, tozorakimab, showed significant efficacy in late-stage trials, bolstering the company's multi-billion dollar sales outlook.

AZN, AZN, SNY, GSK, GILD, SNY, REGN, GSK, IBB

Taiwan Biotech Firms Joyful: Fortune and PharmaEssentia Report Record August Revenues

Health Technology · economic_daily · 2026-09-08

Taiwanese biotech companies Fortune and PharmaEssentia posted record-breaking August revenues, driven by strong product sales and international market expansion.

Latest in Taiwan

CTBC Financial Subsidiaries Plan $127M Combined Bid for HanTest IPO

Electronic Technology · cnyes · 2026-09-08

CTBC Bank and Taiwan Life Insurance have announced plans to invest up to NT$4.1 billion in the upcoming IPO of semiconductor equipment firm HanTest.

2891, 7856

Eastek Hits Daily Limit Up at Open: What's Driving the Surge?

Electronic Technology · economic_daily · 2026-09-08

Eastek shares surged to the daily limit immediately upon opening today, drawing significant investor attention to the catalysts behind the sudden rally.

Guoqing Tech Surges to Limit Up on Heavy Volume

Electronic Technology · economic_daily · 2026-09-08

Guoqing Tech shares hit the daily limit at the open today amid a significant surge in trading volume, sparking speculation about potential positive news.

Foreign Investors Accumulate Taichung Bank, Driving Ex-Dividend Recovery

Finance · economic_daily · 2026-09-08

Taichung Bank is seeing strong buying interest from foreign institutional investors, fueling optimism for a swift recovery in its ex-dividend price.